当前位置:首页 - 行情中心 - 莱美药业(300006) - 财务分析 - 现金流量表

莱美药业

(300006)

  

流通市值:66.83亿  总市值:66.84亿
流通股本:10.56亿   总股本:10.56亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金199,181,417.46875,887,457.77636,058,697.35417,220,187.31
  收到的税费返还113,611.45819,234.6112,173.959,376.36
  收到其他与经营活动有关的现金70,016,230.37400,066,010.67294,677,756.35205,324,647.42
  经营活动现金流入小计269,311,259.281,276,772,703.05930,748,627.65622,554,211.09
  购买商品、接受劳务支付的现金79,998,810.33317,103,052.72232,072,726.93145,969,819.78
  支付给职工以及为职工支付的现金55,046,203.84168,619,830.47132,311,632.6294,362,544.46
  支付的各项税费18,389,487.1778,213,032.8856,084,344.4339,905,373.95
  支付其他与经营活动有关的现金149,131,461.52686,799,032.3513,727,810.08343,052,165.82
  经营活动现金流出小计302,565,962.861,250,734,948.37934,196,514.06623,289,904.01
  经营活动产生的现金流量净额-33,254,703.5826,037,754.68-3,447,886.41-735,692.92
二、投资活动产生的现金流量:
  收回投资收到的现金500,00020,944,713.4417,720,416.4417,720,416.44
  取得投资收益收到的现金-8,480,059.298,297,016.968,297,016.96
  处置固定资产、无形资产和其他长期资产收回的现金净额227,800314,561.46188,065.88161,874.29
  处置子公司及其他营业单位收到的现金净额-782,459.37782,292.37-
  收到的其他与投资活动有关的现金601,450.6567,50067,50067,500
  投资活动现金流入小计1,329,250.6530,589,293.5627,055,291.6526,246,807.69
  购建固定资产、无形资产和其他长期资产支付的现金7,395,796.6838,155,052.5429,771,340.8819,042,409.76
  投资支付的现金-40,000,00040,000,00030,000,000
  支付其他与投资活动有关的现金187,027.043,835,280.92528,958.81828,713.51
  投资活动现金流出小计7,582,823.7281,990,333.4670,300,299.6949,871,123.27
  投资活动产生的现金流量净额-6,253,573.07-51,401,039.9-43,245,008.04-23,624,315.58
三、筹资活动产生的现金流量:
  吸收投资收到的现金9,114,0004,286,0004,286,0004,086,000
  其中:子公司吸收少数股东投资收到的现金9,114,0004,286,0004,286,0004,086,000
  取得借款收到的现金141,250,000294,953,758.33265,450,000120,000,000
  收到其他与筹资活动有关的现金5,200,687.9127,083,699.2420,439,676.1412,242,437.75
  筹资活动现金流入小计155,564,687.91326,323,457.57290,175,676.14136,328,437.75
  偿还债务支付的现金117,056,250425,664,255.8253,914,255.8194,964,255.8
  分配股利、利润或偿付利息支付的现金2,508,903.0912,346,977.5210,058,843.926,426,222.66
  支付其他与筹资活动有关的现金1,142,245.456,275,908.864,682,272.793,583,402.91
  筹资活动现金流出小计120,707,398.54444,287,142.18268,655,372.51204,973,881.37
  筹资活动产生的现金流量净额34,857,289.37-117,963,684.6121,520,303.63-68,645,443.62
四、汇率变动对现金及现金等价物的影响-665,047.74-962,385.63-498,142.03-178,044.77
五、现金及现金等价物净增加额-5,316,035.02-144,289,355.46-25,670,732.85-93,183,496.89
  加:期初现金及现金等价物余额881,386,085.71,025,675,441.161,025,675,441.161,025,675,441.16
  期末现金及现金等价物余额876,070,050.68881,386,085.71,000,004,708.31932,491,944.27
补充资料:
  净利润--126,531,916.8--28,897,647.52
  资产减值准备-70,683,052.13-1,752,750.17
  固定资产和投资性房地产折旧-28,306,812.62-13,587,201.56
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-28,306,812.62-13,587,201.56
  无形资产摊销-18,924,735.41-9,196,696.3
  长期待摊费用摊销-1,291,758.73-624,770.85
  处置固定资产、无形资产和其他长期资产的损失--34,375.22--27,298.59
  固定资产报废损失-108,299.24-48,167.28
  财务费用--9,949,526.1--5,672,875
  投资损失-21,143,556.14-15,530,666.39
  递延所得税--23,638,306.54--2,973,049.86
  其中:递延所得税资产减少--23,404,185.24--2,866,780.69
    递延所得税负债增加--234,121.3--106,269.17
  存货的减少-39,580,356.07-26,004,000.18
  经营性应收项目的减少-49,271,019.48-48,913,385.81
  经营性应付项目的增加--53,330,108.67--84,115,251.53
  现金的期末余额-881,386,085.7-932,491,944.27
  减:现金的期初余额-1,025,675,441.16-1,025,675,441.16
  现金及现金等价物的净增加额--144,289,355.46--93,183,496.89
公告日期2026-04-232026-03-192025-10-222025-08-22
审计意见(境内)标准无保留意见
TOP↑